Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

recital 6recital 6

Vigente · versión de 31 mar 2024

Citenza

Inteligencia jurídica con fuentes verificables, por Datons.

citenza.io